⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9421 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL7715636 | 0.76 | — | — | |
| SCHEMBL450284 | 0.73 | — | — | |
| SCHEMBL8632982 | 0.73 | — | — | |
| SCHEMBL778160 | 0.71 | — | — | |
| SCHEMBL108935 | 0.59 | — | — | |
| SCHEMBL3010 | 0.59 | — | — | |
| SCHEMBL570870 | 0.50 | — | — | |
| Aziridine SCHEMBL2267 | 0.47 | — | — | |
| Aziridine SCHEMBL16878816 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3572 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339168-A | Fused ring heterocyclic derivative and application thereof in medicine | 西藏海思科制药有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118324782-A | Tricyclic compound for inhibiting HPK1 and medical application thereof | 西藏海思科制药有限公司 | 2024-07-12 | — | — | CN | claimed |
| EP-4384177-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2024-06-19 | — | — | EP | claimed |
| EP-4373821-A1 | GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF | Hepagene Therapeutics (HK) Limited (HK) | 2024-05-29 | — | — | EP | claimed |
| CN-118043314-A | Benzazepine heteroaromatic ring derivative and application thereof in medicine | 西藏海思科制药有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2024091541-A1 | COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS | NEUROCRINE BIOSCIENCES, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024091538-A1 | COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS | NEUROCRINE BIOSCIENCES, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| CN-117897159-A | Heterocyclic compounds and methods of use | 安进公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117715906-A | Glucagon-like peptide-1 receptor modulators and uses thereof | 和博医药有限公司 | 2024-03-15 | — | — | CN | claimed |
| WO-2024051819-A1 | PROPIONIC ACID DERIVATIVE AND USE THEREOF IN MEDICINE | 西藏海思科制药有限公司 | 2024-03-14 | — | — | WO | claimed |
| WO-2000008049-A1 | CYCLIC PEPTIDES WITH ANTAGONISTIC ACTIVITY SPECIFIC FOR BRADYKININ B2 RECEPTOR AND FORMULATIONS CONTAINING THEM | MENARINI RICERCHE S.P.A. (IT) | 2000-02-17 | — | — | WO | claimed |
| WO-1999006436-A1 | BENZYL COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS, INC. (US) | 1999-02-11 | — | — | WO | claimed |
| US-4775753-A | New process for the preparation of pristinamycin IIB derivatives | RHONE-POULENC SANTE (FR) | 1988-10-04 | — | — | US | claimed |
| EP-0135410-B1 | SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC SANTE (FR) | 1988-09-21 | — | — | EP | claimed |
| US-4590004-A | MICROBIOCIDES | RHONE-POULENC SANTE (FR) | 1986-05-20 | — | — | US | claimed |
| EP-0160391-A1 | Carbapenem derivatives and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1985-11-06 | — | — | EP | claimed |
| EP-0072710-A1 | Carbapenem derivatives, their preparation and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1983-02-23 | — | — | EP | claimed |
| US-4200628-A | ANTIBIOTICS, BACTERICIDES | SHIONOGI & CO., LTD. (JP) | 1980-04-29 | — | — | US | claimed |
| EP-0001643-A2 | Aminoglycoside derivatives, process for their manufacture, pharmaceutical compositions and carboxylic acids | SHIONOGI & CO., LTD. (JP) | 1979-05-02 | — | — | EP | claimed |
| US-4099840-A | Multilayer reflector for gas discharge laser | U.S. PHILIPS CORPORATION (US) | 1978-07-11 | — | — | US | claimed |